It is very uncertain whether parachlorometaxylenol with iodine changes endometritis compared with iodine alone (very low certainty).
X‐ray pelvimetry may leads to higher caesarean section compared with no X‐ray pelvimetry (low certainty).
It is very uncertain whether X‐ray pelvimetry changes perinatal mortality compared with no X‐ray pelvimetry (very low certainty).
It is very uncertain whether X‐ray pelvimetry changes wound sepsis compared with no X‐ray pelvimetry (very low certainty).
It is very uncertain whether X‐ray pelvimetry changes blood transfusion compared with no X‐ray pelvimetry (very low certainty).
It is very uncertain whether X‐ray pelvimetry changes scar dehiscence compared with no X‐ray pelvimetry (very low certainty).
It is very uncertain whether X‐ray pelvimetry changes admission to special care baby units compared with no X‐ray pelvimetry (very low certainty).
Monitoring of contractions with internal tocodynamometry showed no clear difference in hyperstimulation compared with external tocodynamometry (moderate certainty).
Monitoring of contractions with internal tocodynamometry showed no clear difference in apgar score less than seven at five minutes compared with external tocodynamometry (moderate certainty).
Monitoring of contractions with internal tocodynamometry showed no clear difference in umbilical artery pH < 7.15 compared with external tocodynamometry (moderate certainty).
Monitoring of contractions with internal tocodynamometry showed no clear difference in umbilical artery pH < 7.16 compared with external tocodynamometry (moderate certainty).
Monitoring of contractions with internal tocodynamometry showed no clear difference in admission to neonatal intensive care compared with external tocodynamometry (moderate certainty).
Monitoring of contractions with internal tocodynamometry showed no clear difference in instrumental vaginal delivery compared with external tocodynamometry (moderate certainty).
Monitoring of contractions with internal tocodynamometry showed no clear difference in caesarean section compared with external tocodynamometry (moderate certainty).
The review found no eligible studies for this question.
Dexamethasone showed no clear difference in neurodevelopmental disability at compared with betamethasone – child outcomes (moderate certainty).
Dexamethasone showed no clear difference in visual impairment compared with betamethasone – child outcomes (low certainty).
Dexamethasone showed no clear difference in hearing impairment compared with betamethasone – child outcomes (moderate certainty).
Dexamethasone showed no clear difference in developmental delay –motor (mild, moderate or severe) compared with betamethasone – child outcomes (moderate certainty).